1-3 of 3
Anna R.K. Franklin, M.D.
Close
Sort by
Journal Articles

Adolescent and Young Adult Patients with Acute Lymphoblastic Leukemia (ALL) Treated with Modified Augmented Berlin-Frankfurt-Muenster (ABFM) Therapy

Michael E. Rytting, MD, Deborah A. Thomas, MD, Elias Jabbour, Anna R.K. Franklin, M.D., Gautam Borthakur, Stefan Faderl, MD, Kurt Schroeder, RN, Farhad Ravandi, MD, Rebecca Garris, BSc, Susan o'Brien, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 1527.
https://doi.org/10.1182/blood.V118.21.1527.1527
Published: 2011
Journal Articles

Final Report of a Phase I Trial of Decitabine with or without hyperCVAD In Relapsed Acute Lymphocytic Leukemia (ALL)

Guillermo Garcia-Manero, MD, Deborah A Thomas, MD, Michael E. Rytting, MD, Susan O'Brien, MD, Anna R.K. Franklin, M.D., Gautam Borthakur, MD, Monica Kwari, BSN, Sam Dara, Hui Yang, MD, PhD, Hagop Kantarjian, MD
Journal: Blood
Blood (2010) 116 (21): 867.
https://doi.org/10.1182/blood.V116.21.867.867
Published: 2010
Journal Articles

Outcome of Adolescents and Young Adults (AYAs) with Non-M3 Acute Myeloid Leukemia (AML) Treated on Children's Oncology Group (COG) Trials Compared to Cancer and Leukemia Group B (CALGB) and Southwest Oncology Group (SWOG) Trials

Anna R.K. Franklin, M.D., Todd A. Alonzo, PhD, Robert B. Gerbing, Kathleen Donohue, M.A., Megan Othus, PhD, John Horan, Elihu H. Estey, MD, Richard A. Larson, MD, William G. Woods, MD
Journal: Blood
Blood (2010) 116 (21): 183.
https://doi.org/10.1182/blood.V116.21.183.183
Published: 2010